+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In-Vitro Toxicology Testing Market - Global Forecast 2026-2032- Product Image
In-Vitro Toxicology Testing Market - Global Forecast 2026-2032- Product Image
New

In-Vitro Toxicology Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 180 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5532927
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The in-vitro toxicology testing market is rapidly redefining safety assessment practices as scientific innovation, regulatory evolution, and commercial needs converge. Senior decision-makers face a dynamic environment requiring strategies that address both operational agility and capability building for future growth.

Market Snapshot: In-Vitro Toxicology Testing Market Growth Trajectory

The in-vitro toxicology testing market transitioned from USD 14.78 billion in 2025 to USD 16.21 billion in 2026, with future projections signaling expansion at a CAGR of 11.52% to reach USD 31.73 billion by 2032. This robust growth aligns with sustained innovation, greater regulatory acceptance of non-animal methods, and heightened demand from pharmaceutical and biotechnology industries. Market momentum is being driven by evolving safety standards and increasing requirements for scalable, predictive solutions that accelerate product development and regulatory compliance across diverse sectors.

Scope & Segmentation

  • Service Modalities: Biochemical assays deliver fundamental toxicity insights, while primary cell culture assays provide data rooted in human biology. Computational toxicology services add predictive modeling capability and help decision-makers reduce timelines and costs.
  • Technology Pathways: High throughput screening—including assay-based and imaging-based modalities—enables efficient analysis of large compound libraries. Microfluidics and organ-on-chip systems facilitate environment-specific testing, reflecting more physiologically relevant outcomes. Three-dimensional culture models introduce new levels of predictive power for complex toxicity profiles.
  • Applications: Applications extend across drug discovery workflows, cosmetics safety testing, regulatory submissions, and risk assessments for pharma and biotech pipelines, ensuring comprehensive coverage for companies operating across highly regulated verticals.
  • End Users: Academic research institutes focus on platform validation and scientific advancement, while contract research organizations (CROs) and pharmaceutical or biotech companies prioritize scalable service models and focus on deploying assays suited to varied risk profiles.
  • Regions: Americas are prioritizing the integration of novel solutions, improvement of regulatory processes, and partnered development pathways. EMEA is advancing the harmonization of standards and increased market consistency. Asia-Pacific, meanwhile, places emphasis on rapid platform adoption, localization of service offerings, and improved cost competitiveness for high-volume testing.

Key Takeaways for Senior Decision-Makers

  • Synergies among microphysiological systems, organ-on-chip platforms, and advanced imaging technologies are advancing physiological relevance and data accuracy in testing programs.
  • Regulatory agencies are increasingly accepting sophisticated in-vitro data, provided clear validation methods and transparent reporting procedures support reproducibility among labs and stakeholders.
  • Organizations are proactively shifting procurement strategies, including supplier diversification and consideration of regional manufacturing, to buffer against global market volatility.
  • Collaborative models between platform developers, CROs, and life sciences companies are supporting the rapid integration of innovative assays and co-development of new methodologies tailored to emerging industry needs.
  • Investment focus gravitates toward solutions demonstrating robust validation, reliable scaling, and clear regulatory readiness, as overall commercial performance is intertwined with systematic trust and process efficiency.
  • Strategic approaches to regional differentiation—accounting for policy variation, infrastructure readiness, and supplier networks—are increasingly necessary for ensuring sustained growth and market adaptability.

Tariff Impact: Navigating Complexity and Strengthening Resilience

Recent trade policy adjustments, notably new US tariffs in 2025, have introduced added operational challenges and cost pressures for in-vitro toxicology providers. Organizations are responding with supply chain diversification, localized manufacturing strategies, and renegotiated procurement agreements to effectively minimize tariff burden. These measures, while managing increased input costs, are simultaneously catalyzing process innovations in efficiency, reagent utilization, and adaptive inventory management. Providers are focused on sustaining service reliability and maintaining robust global delivery capabilities.

Methodology & Data Sources

This analysis employs a comprehensive multi-source methodology, combining expert interviews, systematic review of technical literature, and extensive data triangulation. Input from laboratory directors, CRO executives, and regulatory experts has been carefully cross-validated with peer-reviewed documentation, delivering rigorous, actionable insights for all stakeholders in the market.

Why This In-Vitro Toxicology Testing Market Report Matters

  • Empowers executive teams and R&D leaders to benchmark technology pathways and procurement options supporting operational resilience and targeted innovation investments.
  • Provides actionable segmentation and regional strategy insights to enable tailored approaches for partnership development, regulatory alignment, and cross-border operations.
  • Supports informed decision-making around evolving commercial models, validation strategies, and the integration of computational tools to achieve predictive, efficient safety assessment programs.

Conclusion

The in-vitro toxicology testing market continues to evolve at the intersection of scientific progress, regulatory expectations, and operational innovation. Organizations that prioritize validation strength, dependable supply chains, and seamless data integration are best placed to lead in the advancing field of predictive safety science.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. In-Vitro Toxicology Testing Market, by Service Type
8.1. Biochemical Assays
8.2. Cell Culture Assays
8.2.1. Cell Line Assays
8.2.2. Primary Cell Assays
8.3. Computational Models
9. In-Vitro Toxicology Testing Market, by Technology
9.1. High Throughput Screening
9.1.1. Assay Based
9.1.2. Imaging Based
9.2. Microfluidics
9.3. Organ On Chip
9.4. Three Dimensional Culture
10. In-Vitro Toxicology Testing Market, by Application
10.1. Cosmetics Testing
10.1.1. Ocular Irritation
10.1.2. Skin Irritation
10.2. Drug Discovery
10.2.1. Lead Optimization
10.2.2. Target Validation
10.3. Safety Assessment
10.3.1. Carcinogenicity
10.3.2. Cytotoxicity
10.3.3. Genotoxicity
11. In-Vitro Toxicology Testing Market, by End User
11.1. Academic And Research Institutes
11.2. Contract Research Organizations
11.2.1. Large Scale CROs
11.2.2. Small Scale CROs
11.3. Pharma And Biotech
11.3.1. Large Pharma
11.3.2. Small And Medium Biotech
12. In-Vitro Toxicology Testing Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. In-Vitro Toxicology Testing Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. In-Vitro Toxicology Testing Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States In-Vitro Toxicology Testing Market
16. China In-Vitro Toxicology Testing Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Bio-Rad Laboratories, Inc.
17.6. BioIVT LLC
17.7. Catalent, Inc.
17.8. Emulate, Inc.
17.9. Eurofins Scientific SE
17.10. Evotec SE
17.11. Gentronix Limited
17.12. InSphero AG
17.13. Instem plc
17.14. Laboratory Corporation of America Holdings
17.15. Lonza Group Ltd.
17.16. Merck KGaA
17.17. Physiomics plc
17.18. Quest Diagnostics Incorporated
17.19. SGS S.A.
17.20. Stemina Biomarker Discovery, Inc.
17.21. Thermo Fisher Scientific Inc.
17.22. WuXi AppTec Co., Ltd.
17.23. Xenometrix AG
List of Figures
FIGURE 1. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY BIOCHEMICAL ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY BIOCHEMICAL ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY BIOCHEMICAL ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL LINE ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL LINE ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL LINE ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PRIMARY CELL ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PRIMARY CELL ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PRIMARY CELL ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COMPUTATIONAL MODELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COMPUTATIONAL MODELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COMPUTATIONAL MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ASSAY BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ASSAY BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ASSAY BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY IMAGING BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY IMAGING BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY IMAGING BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY MICROFLUIDICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ORGAN ON CHIP, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ORGAN ON CHIP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ORGAN ON CHIP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY THREE DIMENSIONAL CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY THREE DIMENSIONAL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY THREE DIMENSIONAL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OCULAR IRRITATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OCULAR IRRITATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OCULAR IRRITATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SKIN IRRITATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SKIN IRRITATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SKIN IRRITATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TARGET VALIDATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TARGET VALIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CARCINOGENICITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CARCINOGENICITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CARCINOGENICITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CYTOTOXICITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CYTOTOXICITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CYTOTOXICITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY GENOTOXICITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY GENOTOXICITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY GENOTOXICITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY LARGE SCALE CROS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY LARGE SCALE CROS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY LARGE SCALE CROS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SMALL SCALE CROS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SMALL SCALE CROS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SMALL SCALE CROS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY LARGE PHARMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY LARGE PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SMALL AND MEDIUM BIOTECH, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SMALL AND MEDIUM BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SMALL AND MEDIUM BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)
TABLE 146. EUROPE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. EUROPE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 149. EUROPE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 151. EUROPE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. EUROPE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 153. EUROPE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 154. EUROPE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 155. EUROPE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. EUROPE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 157. EUROPE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)
TABLE 170. AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 172. AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 173. AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 174. AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 175. AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 176. AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 177. AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 178. AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 179. AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 181. AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 195. ASEAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. ASEAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 197. ASEAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 198. ASEAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 199. ASEAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 200. ASEAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. ASEAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 202. ASEAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 203. ASEAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 204. ASEAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. ASEAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 206. ASEAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)
TABLE 207. GCC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. GCC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 209. GCC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 210. GCC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 211. GCC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 212. GCC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. GCC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 214. GCC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 215. GCC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 216. GCC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 217. GCC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 218. GCC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)
TABLE 231. BRICS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. BRICS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 233. BRICS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 234. BRICS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 235. BRICS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 236. BRICS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 237. BRICS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 238. BRICS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 239. BRICS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 240. BRICS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 241. BRICS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 242. BRICS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)
TABLE 243. G7 IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. G7 IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 245. G7 IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 246. G7 IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 247. G7 IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 248. G7 IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 249. G7 IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 250. G7 IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 251. G7 IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 252. G7 IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. G7 IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 254. G7 IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)
TABLE 255. NATO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. NATO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 257. NATO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 258. NATO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 259. NATO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 260. NATO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 261. NATO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 262. NATO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 263. NATO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 264. NATO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 265. NATO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 266. NATO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)
TABLE 280. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 281. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 282. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE ASSAYS, 2018-2032 (USD MILLION)
TABLE 283. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 284. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2032 (USD MILLION)
TABLE 285. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 286. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS TESTING, 2018-2032 (USD MILLION)
TABLE 287. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 288. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SAFETY ASSESSMENT, 2018-2032 (USD MILLION)
TABLE 289. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 290. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 291. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMA AND BIOTECH, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this In-Vitro Toxicology Testing market report include:
  • Bio-Rad Laboratories, Inc.
  • BioIVT LLC
  • Catalent, Inc.
  • Emulate, Inc.
  • Eurofins Scientific SE
  • Evotec SE
  • Gentronix Limited
  • InSphero AG
  • Instem plc
  • Laboratory Corporation of America Holdings
  • Lonza Group Ltd.
  • Merck KGaA
  • Physiomics plc
  • Quest Diagnostics Incorporated
  • SGS S.A.
  • Stemina Biomarker Discovery, Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.
  • Xenometrix AG

Table Information

Report AttributeDetails
No. of Pages180
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 16.21 Billion
Forecasted Market Value ( USD ) by 2032 $ 31.73 Billion
Compound Annual Growth Rate11.5%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

In-vitro Toxicology Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

In-vitro Toxicology Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Toxicology Testing of Daily Chemical Products & Cosmetics Market - Global Forecast 2025-2030 - Product Image

Toxicology Testing of Daily Chemical Products & Cosmetics Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
In-Vitro Toxicology Assays Market - Global Strategic Business Report - Product Image

In-Vitro Toxicology Assays Market - Global Strategic Business Report

  • Report
  • 481 Pages
  • Global
From
In-Vitro Toxicology Testing Market Report 2025 - Product Image

In-Vitro Toxicology Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
In Vitro Toxicology Testing - Global Strategic Business Report - Product Image

In Vitro Toxicology Testing - Global Strategic Business Report

  • Report
  • 159 Pages
  • Global
From

About the In Vitro Toxicology Testing Market

In Vitro Toxicology Testing is a type of diagnostic testing used to assess the potential toxicity of a substance or product. It is used to evaluate the safety of a product or substance before it is released into the environment or used in humans. In Vitro Toxicology Testing is conducted in a laboratory setting, using cell cultures, animal models, and other methods to assess the potential toxicity of a substance or product. The tests are designed to identify potential adverse effects on the environment, humans, and animals. The results of the tests are used to inform decisions about the safety of a product or substance. Some companies in the In Vitro Toxicology Testing market include Charles River Laboratories, Eurofins Scientific, Covance, SGS, and Intertek. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.